## **Core Concept**
Toxoplasmosis is a parasitic infection caused by *Toxoplasma gondii*, which can be particularly severe in pregnant women due to the risk of transmission to the fetus. The management of toxoplasmosis during pregnancy involves the use of antiparasitic medications to reduce the risk of fetal infection and mitigate the severity of the disease.

## **Why the Correct Answer is Right**
The correct answer, **Spiramycin**, is a macrolide antibiotic that is effective against *Toxoplasma gondii*. It is the preferred choice for pregnant women because it reduces the transmission rate of *T. gondii* from mother to fetus. Spiramycin achieves high concentrations in the placenta and can decrease the parasitic load, thereby reducing the risk of congenital toxoplasmosis.

## **Why Each Wrong Option is Incorrect**
- **Option A: Pyrimethamine** is a folic acid antagonist used in combination with sulfadiazine for treating toxoplasmosis. However, it is not the first choice in pregnancy due to its potential to cause folate deficiency and kernicterus in the newborn.
- **Option B: Sulfadiazine** is often used in combination with pyrimethamine for the treatment of toxoplasmosis. Like pyrimethamine, it is not the preferred choice for pregnant women due to potential adverse effects.
- **Option D: Atovaquone** is an alternative treatment for toxoplasmosis but is not typically used as the first-line treatment in pregnancy due to limited data on its safety and efficacy in pregnant women.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Spiramycin is used to prevent maternal-fetal transmission of toxoplasmosis**, and it does not treat the fetus if already infected. Pregnant women with toxoplasmosis should be managed carefully, considering the risks and benefits of treatment.

## **Correct Answer:** . Spiramycin